b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">\n        <PMID Version="1">30833149</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>25</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1743-6109</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>16</Volume>\n                    <Issue>4</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>04</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>The journal of sexual medicine</Title>\n                <ISOAbbreviation>J Sex Med</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>A Comparison of the Efficacy and Safety Between Hyaluronic Acid and Polylactic Acid Filler Injection in Penile Augmentation: A Multicenter, Patient/Evaluator-Blinded, Randomized Trial.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>577-585</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S1743-6095(19)30312-1</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsxm.2019.01.310</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND">Studies about the clinical utility of fillers on penile augmentation (PA) are lacking. Furthermore, no randomized study has compared the utilities of fillers.</AbstractText>\n                <AbstractText Label="AIM">To compare the efficacy and safety between hyaluronic acid (HA) and polylactic acid (PLA) filler injection for PA.</AbstractText>\n                <AbstractText Label="METHODS">This prospective, randomized patient/evaluator-blind, comparative multicenter study consisted of an initial 2-week baseline period and 48-week patient/evaluator-blind post-injection period. 72 patients with small penis syndrome were enrolled from 3 institutions between March-July 2016. Patients were divided into 2\xc2\xa0groups: the HA group, comprising 36 patients injected with HA, and the PLA group, comprising 36 patients injected with PLA.</AbstractText>\n                <AbstractText Label="MAIN OUTCOME MEASURES">Penile girth and satisfaction were assessed at baseline and at 4, 12, 24, and 48 weeks after injection.</AbstractText>\n                <AbstractText Label="RESULTS">Penile girth increases adequately lasted \xe2\x89\xa448 weeks in both groups (16.95 \xc2\xb1 10.53 and 13.49 \xc2\xb1 9.98 mm of mean increase in the HA and PLA groups, respectively; P &lt; .001). The mean penile girth increase in the HA group was significantly greater than that in the PLA group at 4 weeks (P &lt; .001). Subsequently, it gradually decreased and was no longer significantly different at 48 weeks (P\xc2\xa0= .075). Satisfaction levels increased after injection and were maintained \xe2\x89\xa448 weeks. No significant differences were observed in the overall satisfaction level between the groups (P &gt; .05). Filler injection-related adverse events were mild and transient and occurred in 1 and 3 patients in the HA and PLA groups, respectively.</AbstractText>\n                <AbstractText Label="CLINICAL IMPLICATIONS">This study provides an overview of the efficacy and safety of HA and PLA fillers, which are the most commonly used soft tissue fillers for PA.</AbstractText>\n                <AbstractText Label="STRENGTH AND LIMITATIONS">This study, to our knowledge, is the first to compare the efficacy and safety between different filler injections for human PA. However, it was impossible to perform a researcher-blinded trial because of the unique properties of fillers, and 31 patients (43.1%) were dropped during the study period.</AbstractText>\n                <AbstractText Label="CONCLUSIONS">Both HA and PLA filler injections for PA led to a significant augmentative effect without serious adverse events and had clinically comparable efficacy and safety. Yang DY, Ko K, Lee SH, et\xc2\xa0al. A Comparison of the Efficacy and Safety Between Hyaluronic Acid and Polylactic Acid Filler Injection in Penile Augmentation: A Multicenter, Patient/Evaluator-Blinded, Randomized Trial. J Sex Med 2019;16:577-585.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Yang</LastName>\n                    <ForeName>Dae Yul</ForeName>\n                    <Initials>DY</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Urology, College of Medicine, Hallym University, Kangdong Sacred Heart Hospital, Seoul, Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ko</LastName>\n                    <ForeName>Kyungtae</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Urology, College of Medicine, Hallym University, Kangdong Sacred Heart Hospital, Seoul, Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Seong Ho</ForeName>\n                    <Initials>SH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Urology, College of Medicine, Hallym University, Dongtan Sacred Heart Hospital, Hwaseong, Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Won Ki</ForeName>\n                    <Initials>WK</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Urology, College of Medicine, Hallym University, Chuncheon Sacred Heart Hospital, Chuncheon, Korea. Electronic address: rheewk@hanmail.net.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <DataBankList CompleteYN="Y">\n                <DataBank>\n                    <DataBankName>ClinicalTrials.gov</DataBankName>\n                    <AccessionNumberList>\n                        <AccessionNumber>NCT02833532</AccessionNumber>\n                    </AccessionNumberList>\n                </DataBank>\n            </DataBankList>\n            <PublicationTypeList>\n                <PublicationType UI="D003160">Comparative Study</PublicationType>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016448">Multicenter Study</PublicationType>\n                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>03</Month>\n                <Day>02</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Netherlands</Country>\n            <MedlineTA>J Sex Med</MedlineTA>\n            <NlmUniqueID>101230693</NlmUniqueID>\n            <ISSNLinking>1743-6095</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011091">Polyesters</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>459TN2L5F5</RegistryNumber>\n                <NameOfSubstance UI="C033616">poly(lactide)</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>9004-61-9</RegistryNumber>\n                <NameOfSubstance UI="D006820">Hyaluronic Acid</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003357" MajorTopicYN="N">Cosmetic Techniques</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006820" MajorTopicYN="N">Hyaluronic Acid</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007267" MajorTopicYN="N">Injections</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010413" MajorTopicYN="N">Penis</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011091" MajorTopicYN="N">Polyesters</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Augmentation</Keyword>\n            <Keyword MajorTopicYN="Y">Filler</Keyword>\n            <Keyword MajorTopicYN="Y">Hyaluronic Acid</Keyword>\n            <Keyword MajorTopicYN="Y">Penis</Keyword>\n            <Keyword MajorTopicYN="Y">Polylactic Acid</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>19</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>21</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>6</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>5</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>6</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30833149</ArticleId>\n            <ArticleId IdType="pii">S1743-6095(19)30312-1</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.jsxm.2019.01.310</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'